PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects (Q46724516)
Jump to navigation
Jump to search
scientific article published on 27 September 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects |
scientific article published on 27 September 2005 |
Statements
1 reference
PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects (English)
1 reference
Karoline V Gleixner
1 reference
Matthias Mayerhofer
1 reference
Karl J Aichberger
1 reference
Sophia Derdak
1 reference
Karoline Sonneck
1 reference
Alexandra Böhm
1 reference
Alexander Gruze
1 reference
Puchit Samorapoompichit
1 reference
Paul W Manley
1 reference
Doriano Fabbro
1 reference
Winfried F Pickl
1 reference
Christian Sillaber
1 reference
Peter Valent
1 reference
27 September 2005
1 reference
1 reference
107
1 reference
2
1 reference
752-759
1 reference
Identifiers
1 reference
1 reference